Clinical Trial Update: Carfilzomib and Belatacept for Desensitization [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial testing desensitization with carfilzomib and belatacept in highly sensitized kidney transplant candidates; the study is currently ACTIVE_N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Kyprolis (carfilzomib)
• Nulojix (belatacept)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Highly Sensitized Prospective Kidney Transplant Recipients | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING